CALL TO ACTION: Tell FDA to deny drugmakers’ request
Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW!
Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW!
How can you make sure you receive quality, legitimate compounded prescriptions? Here are some tips.
APC CEO Scott Brunner appeared on the Scripps News show “America On The Docket,” talking about the “brewing legal battle” over compounded tirzepatide and semaglutide.
In a win for continued patient access to compounded versions of Eli Lilly’s Mounjaro and Zepbound, FDA clarified today that pharmacies may continue to prepare copies of those FDA-approved drugs, at least for now.
Earning the Advanced Certified Pharmacy Technician Certification from the Pharmacy Technician Certification Board is a great way to boost your professional skills and career opportunities.
Mentors play a crucial role in career advancement by offering guidance, encouragement, advocacy, and networking potential. Identifying the right mentor within your industry is essential.
As of this afternoon, the FDA Drug Shortage List is showing that the shortage of tirzepatide injection is “resolved.” Pharmacies must immediately cease preparing and dispensing compounded copies of Mounjaro and Zepbound.
A compounding pharmacy can help compound a medication into a pet-friendly dosage form unique to your pet’s needs. They also stock flavors like beef, chicken, liver, fish, bacon and apple, which help entice pets to take their meds.
If you compound GLP-1s or any drug that’s in shortage, you need to read this. It’s one click and just a few pages — but they’re critical pages.
A new document provides compounding pharmacies best practices for dispensing customized medications that are in shortage, including GLP-1 drugs such as semaglutide and tirzepatide.
In the compounding world, not much gets more shocked faces and chuckles than discussing the famous rectal rocket. Yes, you read that right … rectal rocket.
Mounjaro is available, crows Eli Lilly. Ditto for Zepbound! Novo Nordisk reports the same for Ozempic and Wegovy. Except for one small thing: “Available” is very, very different than “out of shortage.”
You and your team need to operate at the highest ethical and legal standards, and we don’t need to tell you why. Problem: Those standards are complex and constantly changing. If you’re new to compounding, they can be daunting.
We’re seeking passionate, informed, influential compounding leaders to help guide our alliance as members of the APC Board of Directors and of the Pharmacy Compounding Foundation.
The first iteration of Compounding.com 2.0 is up and live, but there’s much more to come. Check it out and watch it expand!
In an interview with Politico last week, Gail Bormel, the director for the FDA’s Office of Compounding Quality and Compliance, once again provided a clear reading of FDA’s ‘essentially a copy’ guidance.
Eli Lilly says that Zepbound will come out of shortage in the next few days, according to news reports, which suggest it could be a problem for compounded versions. Perhaps that’s how Lilly is spinning it.
After a concerted effort by APC, its members, and a coalition of others, the California Board of Pharmacy has postponed its proposed new restrictions on compounded medications after a long and detailed meeting on July 31.
NPR’s Sydney Lupkin continues to achieve balance and accuracy in her reporting on compounding, and we’re grateful for it.
Sometimes, though, even with a lot of phone calls, the message doesn’t get through. Such was the case with Bloomberg.
With all the coverage of GLP-1s, the proposed MOU between states and FDA has faded into the background, but it’s still out there, and APC is keeping track of developments.
If a thread on Reddit is to be believed, one telehealth platform out there is using a contract pharmacy that is inserting Otter Pops as ice packs in the compounded GLP-1 drugs they are dispensing.
If APC had a tattoo on its bicep — if we had a bicep, I mean — it might well read “Consult legal counsel.”
APC sent a letter to the New Mexico Board of Pharmacy this week commenting on its proposed amendments that would align the state with USP (good), but would also require that pharmacists ensure all flavors are inert (yikes).
The APC Board of Directors has voted to name Gina Besteman (previously vice president) the board chair-elect after the resignation of Michelle Moser from the position. Besteman will assume the chair in January 2025.
Earlier this week APC received a letter from the FDA explaining the agency's concerns regarding dosing and patient usage of compounded semaglutide and tirzepatide.
Like humans, pets can develop anxiety and fears. Fireworks are considered a normal tradition on holidays for some cultures but can also frequently trigger anxiety in pets and animals.
If you thought testosterone was only a male hormone, you would be mistaken.
What if you were told a drug that had been around for 100 years acts as a potent antioxidant, improves mitochondrial and cognitive function and mood, and has anti-microbial, anti-inflammatory, and neuroprotective effects?
If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America.